Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
October 15, 2020Frontiers in ChemistryOpen Access

Apigenin as Tumor Suppressor in Cancers: Biotherapeutic Activity, Nanodelivery, and Mechanisms With Emphasis on Pancreatic Cancer

View Full Paper
Ask AI
Bookmark
Share

Authors

MAMilad AshrafizadehShandong Tumor HospitalMBMohammad Reza BakhodaShahrekord University of Medical SciencesZBZahra BahmanpourMcGill University Health Centre

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Ashrafizadeh et al. (2020) studied this question.

synapsesocial.com/papers/6a7e4f95dc5a01fb2fba8a0bhttps://doi.org/10.3389/fchem.2020.00829
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Apigenin, a chemopreventive bioflavonoid, induces AMP‐activated protein kinase activation in human keratinocytes2011 · 57 citations
  2. 2Apigenin inhibits the proliferation of adenoid cystic carcinoma via suppression of glucose transporter-12015 · 47 citations
  3. 3Discoveries and controversies in <scp>BCL</scp>‐2 protein‐mediated apoptosis2015 · 208 citations
  4. 4Apigenin: Selective CK2 inhibitor increases Ikaros expression and improves T cell homeostasis and function in murine pancreatic cancer2017 · 63 citations